JPMORGAN CHASE & CO - 30 May 2025 SCHEDULE 13G/A Report for REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share (REGN)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share
Symbol: REGN
Shares outstanding: 107,786,614 shares
Disclosed Ownership: 4,742,611 shares
Ownership: 4.4%
Form type: SCHEDULE 13G/A
Filing time: 05 Jun 2025, 11:11:31 UTC
Date of event: 30 May 2025
Previous filing: 22 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4.4%	4,742,611	4,189,434	41,470	Rachel Tsvaygoft	Vice President